Seminars in Nephrology
Volume 24, Issue 3 , Pages 179-196 , May 2004

Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome

  • Giuseppe D’Amico

      Affiliations

    • Department of Nephrology and Immunology, San Carlo Borromeo Hospital, Milan, Italy
    • Corresponding Author InformationAddress reprint requests to Giuseppe D’Amico, MD, FRCP, Department of Nephrology and Immunology, San Carlo Borromeo Hospital, Via Pio II, 3, 20153, Milan, Italy

References 

  1. D’Amico G, Ragni A, Gandini E, et al.  Typical and atypical natural history of IgA nephropathy in adult patients. Contrib Nephrol. 1993;104:6–13
  2. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med. 1990;89:209–215
  3. D’Amico G. Natural history of idiopathic IgA nephropathy (Role of clinical and histological prognostic factors). Am J Kidney Dis. 2000;36:227–237
  4. Roodnat JI, Van Stiphout WAHJ, Rosendaal FR, et al.  What do we really know about the long-term prognosis of IgA-nephropathy?. J Nephrol. 1991;3:145–151
  5. D’Amico G, Minetti L, Ponticelli C, et al.  Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med. 1986;59:363–378
  6. Beukhof JR, Kardaun O, Schaafsma W, et al.  Toward individual prognosis of IgA nephropathy. Kidney Int. 1986;29:549–556
  7. Droz D, Kramar A, Nawar T, et al.  Prognostic factors. Contrib Nephrol. 1984;40:202–207
  8. Noel LH, Droz D, Gascon M. Primary IgA nephropathy (From the first described cases to the present). Semin Nephrol. 1987;7:351–354
  9. Velo M, Lozano L, Egido J. Natural history of IgA nephropathy in patients followed up for more than ten years in Spain. Semin Nephrol. 1987;7:346–350
  10. Bogenschütz O, Bohle A, Batz C, et al.  IgA nephritis (On the importance of morphological and clinical parameters in the long-term prognosis of 239 patients). Am J Nephrol. 1990;10:137–147
  11. Rekola S, Bergstrand A, Bucht H. IgA nephropathy (A retrospective evaluation of prognostic indices in 176 patients). Scand J Urol Nephrol. 1989;23:37–50
  12. Rekola S, Bergstrand A, Bucht H. Development of hypertension in IgA nephropathy as a marker of a poor prognosis. Am J Nephrol. 1990;10:290–295
  13. Alamartine E, Sabatier JC, Guerin C, et al.  Prognostic factors in mesangial IgA glomerulonephritis (An extensive study with univariate and multivariate analysis). Am J Kidney Dis. 1991;18:12–19
  14. Johnston PA, Brown JS, Braumholtz DA, et al.  Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC glomerulonephritis Registry. Q J Med. 1992;84:619–627
  15. Payton CD, McLay A, Boulton Jones JM. Progressive IgA nephropathy (The role of hypertension). Nephrol Dial Transplant. 1988;2:138–142
  16. Nicholls KM, Fairley KF, Downling JP, et al.  The clinical course of mesangial IgA associated nephropathy in adults. Q J Med. 1984;53:227–250
  17. Ibels LS, Györy AZ. IgA nephropathy (Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature). Medicine. 1994;73:79–102
  18. Woo KT, Edmondson RPS, Wu AYT, et al.  The natural history of IgA nephritis in Singapore. Clin Nephrol. 1986;25:15–21
  19. Kusumoto Y, Takebayashi S, Taguchi T, et al.  Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and adult Japanese. Clin Nephrol. 1987;28:118–124
  20. Katafuchi R, Oh Y, Hori K, et al.  An important role of glomerular segmental lesions on progression of IgA nephropathy (A multivariate analysis). Clin Nephrol. 1994;41:191–198
  21. Yagame M, Suzuki D, Jinde K, et al.  Value of pathological grading in prediction of renal survival in IgA nephropathy. Nephrology. 1996;2:107–117
  22. Koyama A, Igarashi M, Kobayashi M, et al.  Natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis. 1997;29:526–532
  23. Li PKT, Leung Ho KK, Szeto CC, et al.  Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant. 2002;17:64–69
  24. Wyatt RJ, Julian BA, Bhathena DB, et al.  IgA nephropathy (Presentation, clinical course, and prognosis in children and adults). Am J Kidney Dis. 1984;4:192–200
  25. Radford MG, Donadio JV, Bergstralh EJ, et al.  Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997;8:199–207
  26. Haas M. Histologic subclassification of IgA nephropathy (A clinicopathologic study of 244 cases). Am J Kidney Dis. 1997;29:829–842
  27. Bartosik LP, Lajoie G, Sugar L, et al.  Predicting progression in IgA nephropathy. Am J Kidney Dis. 2001;38:728–735
  28. Geddes CC, Rauta V, Gronhagen-Riska C, et al.  A tricontinental view of IgA nephropathy. Nephrol Dial Transplant. 2003;18:1541–1548
  29. Yaguchi Y, Tomino Y, Funabiki K, et al.  Comparative studies of clinicopathologic changes in patients with adult- and juvenile-onset of IgA nephropathy. J Nephrol. 1994;7:182–185
  30. Wyatt RJ, Kritchevsky SB, Woodford SY, et al.  IgA nephropathy (Long-term prognosis for pediatric patients). J Pediatr. 1995;127:913–919
  31. Linné T, Aperia A, Broberger O, et al.  Course of renal function in IgA glomerulonephritis in children and adolescents. Acta Pediatr Scand. 1982;71:735–743
  32. Lévy M, Gonzalez-Burchard G, Broyer M, et al.  Berger’s disease in children. Natural history and outcome. Medicine. 1985;64:157–180
  33. Hattori S, Karashima S, Furuse A, et al.  Clinicopathological correlation of IgA nephropathy in children. Am J Nephrol. 1985;5:182–189
  34. Andreoli SP, Yum MN, Bergstein JM. IgA nephropathy in children (Significance of glomerular basement membrane deposition of IgA). Am J Nephrol. 1986;6:28–33
  35. Berg UB. Long term follow up of renal function in IgA nephropathy. Arch Dis Child. 1991;66:588–592
  36. Yoshikawa N, Ito H, Nakamura H. Prognostic indicators in childhood IgA nephropathy. Nephron. 1992;60:60–67
  37. Hogg RJ, Silva FG, Wyatt RJ, et al.  Prognostic indicators in children with IgA nephropathy. Report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol. 1994;8:15–20
  38. Yoshikawa N, Iijima K, Matsuyama S, et al.  Repeat renal biopsy in children with IgA nephropathy (Sequential study). Clin Nephrol. 1990;33:160–167
  39. Packham DK, Yan HD, Hewitson TD, et al.  The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephritic range proteinuria in IgA nephropathy. Clin Nephrol. 1996;46:225–229
  40. D’Amico G, Colasanti G, Barbiano di Belgioioso G, et al.  Long-term follow-up of IgA mesangial nephropathy (Clinico-histological study in 374 patients). Semin Nephrol. 1987;4:355–358
  41. Donadio JV, Bergstralh EJ, Grande JP, et al.  Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant. 2002;17:1197–1203
  42. Kobayashi Y, Kokubo T, Horii A, et al.  Prognostic prediction of long-term clinical courses in individual IgA nephropathy patients. Nephrology. 1997;3:35–40
  43. Frimat L, Briançon S, Hestin D, et al.  IgA nephropathy (Prognostic classification of end-stage renal failure). Nephrol Dial Transplant. 1997;12:2569–2575
  44. Vleming LJ, De Fijter JW, Westendorp RGJ, et al.  Histomorphometric correlates of renal failure in IgA nephropathy. Clin Nephrol. 1998;49:337–344
  45. Rychlik I, Andrasxsy K, Waldherr R, et al.  Clinical features and natural history of IgA nephropathy. Ann Med Interne. 1999;150:117–126
  46. Daniel L, Sainna Y, Giorgi R, et al.  Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis. 2000;35:13–20
  47. Syrjänen J, Mustonen J, Pasternack A. Hypertryglyceridaemia and hyperuricemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant. 2000;15:34–42
  48. Rauta V, Finne P, Fagerudd J, et al.  Factors associated with progression of IgA nephropathy are related to renal function. A model for estimating risk of progression in mild disease. Clin Nephrol. 2002;58:85–94
  49. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease (A meta-analysis). J Am Soc Nephrol. 2000;11:319–329
  50. Eiro M, Katoh T, Kuriki M, et al.  The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy. Nephron. 2002;90:432–441
  51. Nagy J, Miltényi M, Dobos M, et al.  Tubular proteinuria in IgA glomerulonephritis. Clin Nephrol. 1987;27:76–78
  52. Woo KT, Lau YK, Lee GSL, et al.  Pattern of proteinuria in IgA nephritis by SDS-PAGE (Clinical significance). Clin Nephrol. 1991;36:6–11
  53. D’Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int. 2003;63:809–825
  54. Ohno I, Hosoya T, Gomi H, et al.  Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron. 2001;87:333–339
  55. Kang DH, Nakagawa T, Feng L, et al.  A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13:288–289
  56. Schena FP. Markers of progression in IgA nephropathy. J Nephrol. 2001;14:554–574
  57. Wyatt RJ, Emancipator SN, Kon V, et al.  IgA nephropathy databank (Development of a system for management of renal biopsy acquired data). Am J Kidney Dis. 1997;29:817–828
  58. Lee KSM, Rao VM, Franklin WA, et al.  IgA nephropathy (Morphological predictors of progressive renal disease). Hum Pathol. 1982;13:314–322
  59. Pirani CL, Salinas-Madrigal L. Evaluation of percutaneous renal biopsy. Pathol Ann. 1968;3:249–296
  60. Lee SMK. Prognostic indicators of progressive renal disease in IgA nephropathy (Emergence of a new histologic grading system). Am J Kidney Dis. 1997;29:953–958
  61. D’Amico G, Napodano P, Ferrario F, et al.  Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. Kidney Int. 2001;59:682–692
  62. Szeto CC, Lai FMM, To KF, et al.  The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med. 2001;110:434–437
  63. Nieuwhof C, Kruytzer M, Frederiks P, et al.  Chronicity Index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy. Am J Kidney Dis. 1998;31:962–970
  64. Feehally J. Predicting prognosis in IgA nephropathy. Am J Kidney Dis. 2001;38:881–883
  65. Hsu SIH, Ramirez SB, Winn PM, et al.  Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int. 2000;57:1818–1835
  66. Schena FP. Immunogenetic aspects of primary IgA nephropathy. Kidney Int. 1995;48:1998–2013
  67. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037–2048
  68. Frimat L, Kessler M. Controversies concerning the importance of genetic polymorphism in IgA nephropathy. Nephrol Dial Transplant. 2002;17:542–545
  69. Tang S, Lai KN. Gene polymorphism in IgA nephropathy. Nephrology. 2001;6:63–70
  70. Galla JH. Molecular genetics in IgA nephropathy. Nephron. 2001;88:107–112
  71. Schena FP, D’Altri C, Cerullo G, et al.  ACE gene polymorphism and IgA nephropathy (An ethnically homogeneous study and a meta-analysis). Kidney Int. 2001;60:732–740
  72. Suzuki S, Suzuki Y, Kobayashi Y. Insertion/deletion polymorphism in ACE gene is not associated with renal progression in Japanese patients with IgA nephropathy. Am J Kidney Dis. 2000;35:896–903
  73. Delos Santos NM, Ault BH, Gharavi AG, et al.  Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy. Pediatr Nephrol. 2002;17:496–502
  74. Goto S, Narita I, Saito N, et al.  A(−20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. Kidney Int. 2002;62:980–985
  75. Nagasawa R, Matsumura O, Marayama N, et al.  T-cell receptor beta-chain gene polymorphism and the prognosis of IgA nephropathy in Japanese patients. Nephron. 1995;70:502–503
  76. Deenitchina SS, Shinozaki M, Hirano T, et al.  Association of a T-cell receptor constant alpha chain gene polymorphism with progression of IgA nephropathy in Japanese patients. Am J Kidney Dis. 1999;34:279–288
  77. Morita T, Ito H, Shehiro T, et al.  Effect of polymorphism of endothelial nitric oxide synthase gene in Japanese patients with IgA nephropathy. Clin Nephrol. 1999;52:203–209
  78. Shu KH, Lee SH, Cheng CH, et al.  Impact of interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphism on IgA nephropathy. Kidney Int. 2000;58:783–789
  79. Watanabe M, Iwano M, Akai Y, et al.  Association of interleukin-1 receptor antagonist gene polymorphism with IgA nephropathy. Nephron. 2002;91:744–746
  80. Masutani K, Miyake K, Nakashima H, et al.  Impact of interferon-γ and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients. Am J Kidney Dis. 2003;41:371–379
  81. Szelestei T, Bähring S, Kovàcs T, et al.  Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy. Am J Kidney Dis. 2000;36:468–473
  82. Aupetit C, Drouet M, Pinaud E, et al.  Alleles of the α1 immunoglobulin gene 3′ enhancer control evolution of IgA nephropathy toward renal failure. Kidney Int. 2000;58:966–971
  83. Pei Y, Scholey J, Thai K, et al.  Association of angiotensinogen gene T235 variant with progression of immunoglobin a nephropathy in Caucasian patients. J Clin Invest. 1997;100:814–820
  84. Yoon HJ, Kim H, Kim HL, et al.  Interdependent effect of angiotensin-converting enzyme and platelet-activating factor acetylhydrolase gene polymorphisms on the progression of immunoglobulin A nephropathy. Clin Genet. 2002;62:128–134
  85. Schena FP, Cerullo G, Rossini M, et al.  Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol. 2002;13:453–460
  86. Gharavi AG, Yan Y, Scolari F, et al.  IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23. Nat Genet. 2000;26:354–357
  87. Goumenos D, Ahuja M, Shortland JR, et al.  Can immunosuppressive drugs slow the progression of IgA nephropathy?. Nephrol Dial Transplant. 1995;10:1173–1181
  88. Schöll U, Wastl U, Risler T, et al.  The point of no return and the rate of progression in the natural history of IgA nephritis. Clin Nephrol. 1999;52:285–292
  89. D’Amico G. Natural history and prognosis of chronic primary glomerulonephritis. In:  El Nahas M editors. Mechanisms and Clinical Management of Chronic Renal Failure. Oxford: Oxford University Press; 2000;p. 241–264
  90. D’Amico G. Tubulo-interstitial damage in glomerular diseases (Its role in the progression of the renal damage). Nephrol Dial Transplant. 1998;13:80S–85S
  91. Remuzzi G. Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury. Curr Opin Nephrol Hypertens. 1995;4:339–342
  92. D’Amico G. Tubulointerstitium as predictor of renal progression in glomerular diseases. Nephron. 1999;83:289–295
  93. Katafuchi R, Takebayashi S, Taguchi T. Hypertension-related aggravation of IgA nephropathy (A statistical approach). Clin Nephrol. 1988;30:261–269
  94. Yoshikawa N, Iijima K, Matsuyama S, et al.  Repeat renal biopsy in children with IgA nephropathy. Clin Nephrol. 1990;33:160–167
  95. Hotta O, Furuta T, Chiba S, et al.  Regression of IgA nephropathy (A repeat biopsy study). Am J Kidney Dis. 2002;39:493–502

☆ Supported in part by EU Grant OLG1-CT-2002-01215 and by the Associazione per la Ricerca in Nefrologia.

PII: S0270-9295(04)00003-8

doi: 10.1016/j.semnephrol.2004.01.001

Seminars in Nephrology
Volume 24, Issue 3 , Pages 179-196 , May 2004

Article Tools